Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
Authors
Keywords
-
Journal
PROSTATE
Volume 74, Issue 16, Pages 1691-1696
Publisher
Wiley
Online
2014-09-28
DOI
10.1002/pros.22890
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies
- (2014) Vincenza Conteduca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone
- (2014) Salvatore Luca Burgio et al. ENDOCRINE-RELATED CANCER
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme
- (2013) Barbara A. Foster et al. PLoS One
- Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt
- (2012) Deliu-Victor Matei et al. Clinical Genitourinary Cancer
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer
- (2012) Markus Germann et al. STEM CELLS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Pluripotent Stem Cell Reprogramming Factors by Prostate Tumor Initiating Cells
- (2010) Kyung-Mi Bae et al. JOURNAL OF UROLOGY
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Neuroendocrine differentiation in the progression of prostate cancer
- (2009) Akira Komiya et al. INTERNATIONAL JOURNAL OF UROLOGY
- Distribution of High Chromogranin A Serum Levels in Patients with Nonmetastatic and Metastatic Prostate Adenocarcinoma
- (2009) Alessandro Sciarra et al. UROLOGIA INTERNATIONALIS
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells
- (2008) D. J. Vander Griend et al. CANCER RESEARCH
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started